SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-050515
Filing Date
2021-04-15
Accepted
2021-04-15 08:30:30
Documents
7
Period of Report
2021-05-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2110663-2_def14a.htm DEF 14A 1053915
2 GRAPHIC tm2110663d2-icon_cross4c.jpg GRAPHIC 856
3 GRAPHIC tm2110663d2-icon_tick4c.jpg GRAPHIC 706
4 GRAPHIC tm2110663d2-pc_ceopay4c.jpg GRAPHIC 56427
5 GRAPHIC tm2110663d2-pc_neopay4c.jpg GRAPHIC 55610
6 GRAPHIC tm2110663d2-pc_proxy14c.jpg GRAPHIC 810924
7 GRAPHIC tm2110663d2-pc_proxy24c.jpg GRAPHIC 588911
  Complete submission text file 0001104659-21-050515.txt   3139953
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39044 | Film No.: 21827377
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences